Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinoma

27 Sept 2018

Abstract excerpt

There is a growing need for the discovery of new prognostic factors for cases where the scoring and staging system of hepatocellular carcinoma (HCC) does not result in a clear definition. We analyzed whether AP-2 complex subunit mu (AP2M1) expression could be a new prognostic marker for HCC based on the roles of AP2M1 in influencing hepatocyte growth factor (HGF) promoter regulation and hepatitis C virus (HCV)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30260026
DOI: 10.1002/jcb.27699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinomaPMID 30260026Read ↗

Deciphering the Influence of AP1M2 in Modulating Hepatocellular Carcinoma Growth and Mobility through JNK/ErK Signaling Pathway controlSemantic proximity Read ↗

Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinomaSemantic proximity Read ↗

CENPA and IQGAP3 Identified as Ideal Early-Stage Hepatocellular Carcinoma MarkersSemantic proximity Read ↗

Apelin (APLN) is a biomarker contributing to the diagnosis and prognosis of hepatocellular carcinomaSemantic proximity Read ↗

Prognostic values and clinical relationship of AHSA1 in hepatocellular carcinomaSemantic proximity Read ↗

Diagnostic and prognostic significance of mRNA expressions of apolipoprotein A and C family genes in hepatitis B virus‐related hepatocellular carcinomaSemantic proximity Read ↗

Prognostic implications of alcohol dehydrogenases in hepatocellular carcinomaSemantic proximity Read ↗

Identification of MCM4 as a Prognostic Marker of Hepatocellular CarcinomaSemantic proximity Read ↗

Prognostic implications of alcohol dehydrogenases in hepatocellular carcinomaSemantic proximity Read ↗

Analysis for MBOAT Family Genes in Human Liver Hepatocellular CarcinomaSemantic proximity Read ↗

Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signaturesSemantic proximity Read ↗

Study of the effect of ACYP2 single nucleotide polymorphisms rs843711 and rs843706 in Egyptian patients with hepatocellular carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.